Clinical Research Directory

Inclusion Criteria: * Children who are under 18 years of age, * Have been diagnosed with Hemophilia A by a physician, * Have a factor level of 1% (IU) or less, * Have inhibitors positive or negative, * Have no obstacles to starting subcutaneous (emicizumab) treatment, * Willing to participate in the study Exclusion Criteria: \- Children with a history of cerebrovascular bleeding who present any neurological findings that would prevent participation in the study